Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cerebrospinal fluid tau levels increase with age in healthy individuals.

Dementia and geriatric cognitive disorders - 1 Jan 2000

Blomberg M, Jensen M, Basun H, Lannfelt L, Wahlund L O

Abstract excerpt

Cerebrospinal fluid (CSF) tau is a promising biochemical ante-mortem marker for Alzheimer's disease (AD). Levels are increased in AD compared to other dementias, neurological diseases and healthy controls. An age-related decrease in both soluble tau and tau bound to paired helical filaments has been shown in brains from non-demented subjects. To study tau levels in normal ageing, we investigated CSF in 29 healthy...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aging
Share to Alzheimer Disease
Share to Apolipoproteins E

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cognition Disorders

Share to Magnetic Resonance Imaging

Share to Neuropsychological Tests

Share to tau Proteins

Share to Tomography, Emission-Computed, Single-Photon

Source

Identifiers

PMID: 11173885
DOI: 10.1159/000051246

Genes

APOE

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cerebrospinal fluid tau levels increase with age in healthy individuals.PMID 11173885Read ↗

Tau-mediated Neurodegeneration and Potential Implications in Diagnosis and Treatment of Alzheimer's DiseaseSemantic proximity Read ↗

The application of cerebrospinal fluid biomarkers in early diagnosis of Alzheimer disease.Semantic proximity Read ↗

Sensitivity, specificity, and stability of CSF-tau in AD in a community-based patient sample.Semantic proximity Read ↗

Cerebrospinal Fluid Biomarkers in Familial Forms of Alzheimer's Disease and Frontotemporal Dementia.Semantic proximity Read ↗

Increasing cerebrospinal fluid tau levels in a subgroup of Alzheimer patients with apolipoprotein E allele epsilon 4 during 14 months follow-up.Semantic proximity Read ↗

Tau and apo E in CSF: potential aid for discriminating Alzheimer's disease from other dementias.Semantic proximity Read ↗

Tau in cerebrospinal fluid: a potential diagnostic marker in Alzheimer's disease.Semantic proximity Read ↗

Tau, where are we now?Semantic proximity Read ↗

Tau protein in cerebrospinal fluid from semantic dementia patients.Semantic proximity Read ↗

Cerebrospinal fluid total tau concentration predicts clinical phenotype in Huntington's disease.Semantic proximity Read ↗

Longitudinal stability of CSF tau levels in Alzheimer patients.Semantic proximity Read ↗

Tau aggregation in the hippocampal formation: an ageing or a pathological process?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.